§ Funding Round
Series B funding round for Immunitas Therapeutics raising $58M in August 2021
Series B funding round for Immunitas Therapeutics raising $58M in August 2021
| Investor | Firm Type | Partner |
|---|---|---|
Agent CapitalLEAD | Organization | — |
| Organization | — | |
| Organization | — | |
Domain Associates | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
RA Capital | — | — |
| Organization | — | |
| Angel | netalie nadivi | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | brian halak | |
Mirae Asset | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$97M
Top Valuation
-
Immunitas Therapeutics raised $58M in a Series B round.
The round was announced on 08/01/21.
The round was led by Agent Capital.
